Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cancer Biol Ther ; 13(9): 702-11, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22684580

RESUMEN

Invariant natural killer T (iNKT) cells are a distinct subset of human T cells, which expresses an invariant T cell receptor Vα24 Jα18 and recognizes glycolipid antigens in the context of CD1d molecules. iNKT cells exert pivotal regulatory roles in many immune responses, including antitumor immune responses. Alterations in iNKT cell frequency, phenotype, and activation state have been reported in cancer patients. No data are available on the iNKT cells in malignant pleural mesothelioma (MPM), a rare, but very aggressive, malignancy of the pleura with a very poor prognosis. Here, we studied the frequency, phenotype, and cytokine profile of circulating iNKT cells in MPM patients, and correlated results with tumor histological types (epithelioid, sarcomatoid, biphasic) and clinical stages (I-III). We found that the iNKT cell frequency was significantly increased in MPM patients with epithelioid and sarcomatoid types in comparison with healthy volunteers (HV); only three biphasic mesotheliomas were available in this study, thus no conclusions can be drawn for this MPM type. The increased frequency significantly correlates with the clinical stage of tumor with the highest value at the stage III in both epithelioid and sarcomatoid subtypes. According to the histological types, we measured changes in the frequencies of CD4⁺ CD8⁺ (DP) and CD4⁻CD8⁻ (DN), but not in the cytokine profiles (IFN-γ/IL-4 expression). These results demonstrate that the frequency of iNKT cells is increased in MPM patients and that this increase correlates with MPM type and stage.


Asunto(s)
Mesotelioma/patología , Células T Asesinas Naturales/patología , Neoplasias Pleurales/patología , Adulto , Anciano , Anciano de 80 o más Años , Antígenos CD/metabolismo , Estudios de Casos y Controles , Femenino , Humanos , Interferón gamma/sangre , Interferón gamma/metabolismo , Interleucina-4/sangre , Interleucina-4/metabolismo , Recuento de Linfocitos , Masculino , Mesotelioma/sangre , Mesotelioma/inmunología , Persona de Mediana Edad , Células T Asesinas Naturales/metabolismo , Estadificación de Neoplasias , Fenotipo , Neoplasias Pleurales/sangre , Neoplasias Pleurales/inmunología
2.
Tumori ; 91(1): 101-2, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15850017

RESUMEN

Cardiac metastases are rare in patients affected by colorectal cancer. This is the case of a woman who underwent a colon resection because of a metastatic sigmoid carcinoma, that survived for more than 6 years and died for malignant pericardial effusion.


Asunto(s)
Carcinoma/secundario , Neoplasias Cardíacas/secundario , Neoplasias del Colon Sigmoide/patología , Resultado Fatal , Femenino , Humanos , Derrame Pericárdico/diagnóstico por imagen , Derrame Pericárdico/etiología , Radiografía
3.
Tumori ; 90(6): 622-4, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15762368

RESUMEN

BACKGROUND: The development of secondary soft tissue sarcomas after chemo-radiotherapy is a rare and little known event, but its frequency is increasing. PATIENTS AND METHODS: We report two cases of secondary soft tissue sarcomas. The first is the case of a 51-year-old woman treated for Hodgkin's disease with chemotherapy and radiotherapy 15 years before she developed a high-grade malignant pleural sarcoma. The patient had no history of asbestos exposure. The second is the case of a 64-year-old woman with a giant cell malignant histiocytoma secondary to colorectal cancer treated with surgery and radiotherapy nine years before. The patients were not eligible for surgery or radiotherapy. Both were treated with chemotherapy (ifosfamide and epirubicin) without any relevant secondary effects; however, the response to therapy was poor. CONCLUSIONS: The causes of secondary malignancies are multifactorial, but radiation therapy and chemotherapy are certainly implicated in the development of post-therapy neoplasms that are difficult to treat.


Asunto(s)
Sarcoma Histiocítico/etiología , Neoplasias Inducidas por Radiación/etiología , Neoplasias Primarias Secundarias/etiología , Neoplasias Pleurales/etiología , Sarcoma/etiología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioterapia Adyuvante/efectos adversos , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/radioterapia , Femenino , Sarcoma Histiocítico/tratamiento farmacológico , Enfermedad de Hodgkin/tratamiento farmacológico , Enfermedad de Hodgkin/radioterapia , Humanos , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/tratamiento farmacológico , Neoplasias Primarias Secundarias/tratamiento farmacológico , Neoplasias Pleurales/tratamiento farmacológico , Radioterapia Adyuvante/efectos adversos , Sarcoma/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA